Publication | Closed Access

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

Antifungal AgentAntifungal AgentsMalignant Blood DisorderHematologyImmunologyFungal InfectionsPathologyHematologic MalignanciesClinical MycologyImmunocompromised PatientsMedicine